What changed in this filing

/stocks — the workspaceLOADING

Item 5. Market for Registrant’s Common Equity

2024-04-16 compared with 2023-02-21 · 32 added, 26 removed, 48 unchanged (55% of the section changed)

45 unchanged sentences

Rule 2a-7 under the Investment Company Act.

On March 24, 2023, the Company

held a special meeting of its stockholders (the “special meeting”).

In connection with the votes to approve the Extensions,

the stockholders approved the proposal to amend (the “Charter Amendment”) the Company’s Charter by allowing the Company

to extend (the “Extension”) the date by which it has to consummate a business combination (the “Combination Period”)

for up to an additional six months, from March 30, 2023 to up to September 30, 2023, by depositing into the trust account $125,000 for

each additional one month extension (the “Extension Payment”) in exchange for a non-interest bearing, unsecured promissory

note, convertible at the option of the holder, in full or in part, into units at a price of $10.00 per unit, which units will be identical

to the private placement units issued in connection with the initial public offering of the Company’s units and repayable upon closing

of a business combination (the “Extension Note”).

On March 24, 2023, Holders of 4,097,964 shares of common stock of the Company

properly exercised their right to redeem their shares for cash at a redemption price of approximately $10.40 per share, for an aggregate

redemption amount of approximately $42.6 million, leaving approximately $37.8 million in the trust account, based on the approximately

$80.4 million held in the trust account.

As of March 31, 2023, the amounts due to Holders exercising their right to redeem is presented

as Due to stockholders for redemption of Common Stock in the accompanying condensed consolidated balance sheets.

The amount due to the

redeeming Stockholders was subsequently disbursed on April 10, 2023

On September 29, 2023, the

Company held a special meeting of its stockholders.

The stockholders approved the proposal to amend the Company’s charter by allowing

the Company to extend the Combination Period with a target for up to an additional nine months, from September 30, 2023, to up to June

30, 2024 and proposal to amend the Trust Agreement, allowing the Company to extend the Combination Period for up to an additional nine

months, from September 30, 2023, to up to June 30, 2024, for no contribution to the trust account.

In connection with the votes to approve

the September Extensions, the holders of 1,456,871 shares of common stock of the Company properly exercised and did not reverse, their

right to redeem their shares for cash at a redemption price of $10.79 per share, for an aggregate redemption amount of $15.7 million,

leaving approximately $23.4 million in the trust account after the withdrawal of interest to be paid for taxes.

As of September 30, 2023,

the amounts due to Holders exercising their right to redeem is presented as Due to stockholders for redemption of Common Stock in the

accompanying condensed consolidated balance sheets.

The amount due to the redeeming stockholders was subsequently disbursed on October

(g) Purchases

of Equity Securities by the Issuer and Affiliated Purchasers

Management’s Discussion and

Analysis of Financial Condition and Results of Operations.

References to the “Company,”

“us,” “our” or “we” refer to Welsbach Technology Metals Acquisition Corp.

The following discussion

and analysis of our financial condition and results of operations should be read in conjunction with our audited financial statements

and related notes included herein.

Cautionary Note Regarding Forward-Looking

All statements other than

statements of historical fact included in this Report including, without limitation, statements under this “Management’s Discussion

and Analysis of Financial Condition and Results of Operations” regarding the Company’s financial position, business strategy

and the plans and objectives of management for future operations, are forward- looking statements.

When used in this Report, words such

as “anticipate,” “believe,” “estimate,” “expect,” “intend” and similar expressions,

as they relate to us or the Company’s management, identify forward-looking statements.

Such forward-looking statements are based

on the beliefs of management, as well as assumptions made by, and information currently available to, the Company’s management.

Actual results could differ materially from those contemplated by the forward- looking statements as a result of certain factors detailed

in our filings with the SEC.

All subsequent written or oral forward-looking statements attributable to us or persons acting on the Company’s

behalf are qualified in their entirety by this paragraph.

The following discussion

and analysis of our financial condition and results of operations should be read in conjunction with the financial statements and the

notes thereto contained elsewhere in this Report.

Certain information contained in the discussion and analysis set forth below includes

forward-looking statements that involve risks and uncertainties.

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-K

Item 5. Market for Registrant’s Common Equity